22, 2024 — A study suggests that menopausal hormone therapy (MHT) might have moderate effects on brain health, but this depends ... 25, 2024 — Women worldwide could see better treatment ...
Notes from several investment houses indicate that the insurance giant will no longer cover genetic tests for behavioral health, which includes Myriad's GeneSight, beginning Jan. 1, 2025.
This is the second edition of Giant Leap’s deep dive series, where its investment team explores the technologies and approaches addressing global problems of climate, health and people with commercial ...
Stephens analyst Mason Carrico notes that Myriad Genetics (MYGN ... no longer cover multi-panel genetic tests for behavioral health diagnoses. The announcement lists codes that will be denied ...
Myriad is actively engaging with UnitedHealthcare to discuss the large body of evidence for Myriad’s proprietary and clinically differentiated mental health medication test, GeneSight, and is seeking ...